Trauma Fixation Devices Market Size, Share and COVID-19 Impact Analysis, By Product Type [External Fixation (Unilateral, Bilateral, Circular, and Others), and Internal Fixation (Plates, Screws, Nails)], By Anatomy (Upper Extremity and Lower Extremity), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global trauma fixation devices market size was valued at USD 15.98 billion in 2025. The market is projected to grow from USD 16.84 billion in 2026 to USD 25.6 billion by 2034, exhibiting a CAGR of 5.38% during the forecast period.

Traumatic injury is defined as a physical injury with sudden onset and severity. Traumatic injuries require immediate medical attention and treatment. Trauma fixation devices are used to treat bone fractures and deformities. These devices are used in many orthopedic surgeries and help in fixing bone-related deformities of various anatomical regions such as the spine, cranium, and other extremities. Trauma fixation devices are broadly classified into internal and external fixators. External fixation is often used in fractures that would not be appropriately aligned if a cast was used. In contrast, internal fixation is used to surgically supplement the healing of a bone using screws, plates, and others.

The increasing incidence of trauma, including sports injuries, road accidents, etc., is driving the demand for traumatic fixation devices. For instance, as per the article published by Elsevier in 2019, there were around 178 million new fractures worldwide from 1990. This included 455 million prevalent cases of acute or long-term fracture symptoms.

Impact of COVID-19 on the Trauma Fixation Devices Market

The global trauma fixation devices market experienced a decline in its growth due to the outbreak of COVID-19. The market experienced a decline in its growth as the non-emergency surgeries were postponed and lockdown restrictions were imposed to control the spread of the virus.

• As per the article published by NCBI in 2021, the number of orthopedic surgeries fell by 22.8% during the pandemic in Chile.

Moreover, due to the lockdown restrictions fewer road accidents were reported resulting in lesser demand for traumatic fixation devices.

However, the market experienced a significant recovery in 2021, due to the release of the lockdown and increased diagnosis and treatment of traumatic injuries.

Key Insights

The report will cover the following key insights:

• Incidence of Fracture, by Key Countries/Regions (2020/2021).
• New Product Launches, Key Players.
• Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.).
• Impact of COVID-19 on the Market.

Analysis by Product Type

On the basis of product type, internal fixation devices are expected to grow at a significant CAGR. Factors such as fast recovery, less hospital stay, and low chances of infection have been fueling the segment’s growth during the forecast period.

Moreover, the external fixation devices are expected to grow at a substantial CAGR. The increasing prevalence of bone fractures and new product launches has been fueling the segment’s growth.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America accounts for a significant share of the global trauma fixation devices market. The primary factor responsible for North America’s largest share in the market is the increasing cases of bone deformities and the presence of key market players such as Stryker and Zimmer Biomet.

• According to the Canadian Cancer Society statistics, in 2022, an estimated 8,100 Canadian women are likely to be diagnosed with uterine cancer.

Moreover, Europe is expected to grow at a significant CAGR due to rising awareness about trauma fixation devices in the region and new product launches.

Key Players Covered

The report will include the profiles of key players such as Medtronic, Stryker, DePuy Synthes (Johnson & Johnson), Orthofix US LLC., Zimmer Biomet, Orthofix US LLC., and others.

Segmentation

Key Industry Developments

• March 2022: Orthofix US LLC announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and the first patient cases with the TrueLok EVO Ring Fixation System.
• July 2021: Endeavor Orthopedics announced the U.S. FDA for its Summit Patella Plating System. The system is used for the surgical stabilization of patella fractures at the time of open reduction internal fixation surgeries in adults.    
• September 2019: Zimmer Biomet announced the launch of the RibFix Advantage Intrathoracic Fixation System. It was the first FDA-cleared minimally invasive fixation, stabilization, and fusion system for rib fractures and normal and osteoporotic bone osteotomies.